These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 22414288

  • 1. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
    Li P, Zhang Q, Torossian A, Li ZB, Xu WC, Lu B, Fu S.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):e391-7. PubMed ID: 22414288
    [Abstract] [Full Text] [Related]

  • 2. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.
    Li P, Veldwijk MR, Zhang Q, Li ZB, Xu WC, Fu S.
    BMC Cancer; 2013 Jun 19; 13():297. PubMed ID: 23777562
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of phosphoinositide 3-kinase enhances the cytotoxicity of AG1478, an epidermal growth factor receptor inhibitor, in breast cancer cells.
    Li P, Torossian A, Zhang Q, Xu WC, Fu S.
    Med Oncol; 2012 Dec 19; 29(5):3258-64. PubMed ID: 22729368
    [Abstract] [Full Text] [Related]

  • 4. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2005 Dec 19; 12(4):983-98. PubMed ID: 16322337
    [Abstract] [Full Text] [Related]

  • 5. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.
    Toulany M, Kasten-Pisula U, Brammer I, Wang S, Chen J, Dittmann K, Baumann M, Dikomey E, Rodemann HP.
    Clin Cancer Res; 2006 Jul 01; 12(13):4119-26. PubMed ID: 16818713
    [Abstract] [Full Text] [Related]

  • 6. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ, Zhang L, Liu YP, Xu HM, Sun P, Song JG, Luo YH.
    Zhonghua Zhong Liu Za Zhi; 2013 Mar 01; 35(3):181-6. PubMed ID: 23879997
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab ("Herceptin").
    Fukutome M, Maebayashi K, Nasu S, Seki K, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):528-36. PubMed ID: 16965995
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.
    Li H, Schmid-Bindert G, Wang D, Zhao Y, Yang X, Su B, Zhou C.
    Adv Med Sci; 2011 Oct 01; 56(2):275-84. PubMed ID: 22037177
    [Abstract] [Full Text] [Related]

  • 10. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo.
    Liu Y, Cui B, Qiao Y, Zhang Y, Tian Y, Jiang J, Ma D, Kong B.
    Int J Gynecol Cancer; 2011 Jan 01; 21(1):100-5. PubMed ID: 21330835
    [Abstract] [Full Text] [Related]

  • 11. Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.
    She QB, Solit D, Basso A, Moasser MM.
    Clin Cancer Res; 2003 Oct 01; 9(12):4340-6. PubMed ID: 14555504
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.
    Int J Oncol; 2006 Jul 01; 29(1):269-78. PubMed ID: 16773209
    [Abstract] [Full Text] [Related]

  • 13. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K, Kim M, Seo HS, Shin I.
    Oncol Rep; 2010 Sep 01; 24(3):787-93. PubMed ID: 20664988
    [Abstract] [Full Text] [Related]

  • 14. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C, Dörfler A, Eicheler W, Zips D, Hering S, Solca F, Baumann M, Krause M.
    Strahlenther Onkol; 2007 May 01; 183(5):256-64. PubMed ID: 17497097
    [Abstract] [Full Text] [Related]

  • 15. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.
    Lei Y, Li HX, Jin WS, Peng WR, Zhang CJ, Bu LJ, Du YY, Ma T, Sun GP.
    Int J Radiat Biol; 2013 Dec 01; 89(12):1079-86. PubMed ID: 23875954
    [Abstract] [Full Text] [Related]

  • 16. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
    Geoerger B, Gaspar N, Opolon P, Morizet J, Devanz P, Lecluse Y, Valent A, Lacroix L, Grill J, Vassal G.
    Int J Cancer; 2008 Jul 01; 123(1):209-16. PubMed ID: 18386816
    [Abstract] [Full Text] [Related]

  • 17. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Normanno N, De Luca A, Maiello MR, Campiglio M, Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S.
    J Cell Physiol; 2006 May 01; 207(2):420-7. PubMed ID: 16419029
    [Abstract] [Full Text] [Related]

  • 18. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X, Zhao M, Hao M, Sun X, Wang J, Mao Y, Zu L, Liu J, Shen Y, Wang J, Shen K.
    Mol Cancer Res; 2013 Oct 01; 11(10):1269-78. PubMed ID: 23814023
    [Abstract] [Full Text] [Related]

  • 19. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J, Ding M, Yang L, Liu LZ, Jiang BH.
    Cell Signal; 2007 Dec 01; 19(12):2487-97. PubMed ID: 17826033
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
    Kim K, Wu HG, Jeon SR.
    Anticancer Res; 2015 Jan 01; 35(1):245-53. PubMed ID: 25550557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.